Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CASP3 | P42574 | 4/20 | 0.35 |
| ▸ | MDM4 | O15151 | 2/20 | 0.34 |
| ▸ | TP53 | P04637 | 2/20 | 0.34 |
| ▸ | PIN1 | Q13526 | 1/20 | 0.33 |
| ▸ | TLR2 | O60603 | 2/20 | 0.33 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20764502 | 0.87 | CASP3 (0.42) | CASP3MDM4TP53TLR2EPHX2 | |
| SCHEMBL20764509 | 0.79 | MDM4 (0.35) | CASP3MDM4TP53TLR2 | |
| SCHEMBL20764508 | 0.79 | MDM4 (0.35) | CASP3MDM4TP53TLR2 | |
| SCHEMBL20764467 | 0.74 | MDM4 (0.43) | CASP3MDM4TP53TLR2EPHX2 | |
| SCHEMBL20764469 | 0.74 | MDM4 (0.43) | CASP3MDM4TP53TLR2EPHX2 | |
| SCHEMBL29402067 | 0.74 | CASP3 (0.47) | CASP3MDM4TP53EPHX2KMT2A | |
| SCHEMBL20764453 | 0.72 | CASP1 (0.34) | CASP3MDM4TP53TLR2 | |
| SCHEMBL20764454 | 0.72 | CASP1 (0.34) | CASP3MDM4TP53TLR2 | |
| SCHEMBL8227141 | 0.70 | MDM4 (0.50) | CASP3MDM4TP53TLR2KMT2A | |
| SCHEMBL12292666 | 0.70 | MDM4 (0.50) | CASP3MDM4TP53TLR2KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3672937-A1 | NOVEL CYSTOBACTAMIDE DERIVATIVES | Helmholtz-Zentrum für Infektionsforschung GmbH (DE) | 2020-07-01 | — | — | EP | disclosed |
| WO-2019038405-A1 | NOVEL CYSTOBACTAMIDE DERIVATIVES | Helmholtz-Zentrum für Infektionsforschung GmbH (DE) | 2019-02-28 | — | — | WO | disclosed |